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Noma, an orofacial gangrene and opportunistic infection, affects primarily malnourished children living in
extreme poverty. Neglected, forgotten, unknown by most health workers, noma results in death, disﬁgurement
and disability of some of the world’s most vulnerable children. Noma is a biological indicator of multiple human
rights violations, including the right to food. International support and national attention in countries with noma
are lacking. The end of neglect of noma can lead to the elimination of this horriﬁc childhood disease.
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Noma is a facial gangrene mainly occurring in malnourished chil-
dren aged 1–5 years, living in extreme poverty.1 Besides malnutri-
tion other predisposing factors are measles, malaria, HIV and the
presence of acute necrotizing gingivitis.1,2 Noma is an opportunis-
tic infection, associated with an imbalance of microorganisms. In
the past fusiform and spirochaetal microorganisms, identiﬁed as
Fusiformis fusiformis and Borrelia vincenti, have been identiﬁed
between gangrenous and healthy tissue.3 This resulted in the
historical synonym fusospirochaetal gangrene. However, it still is
unknown which microorganisms play a role in initiating and
expanding this quickly spreading, but non-contagious gangrene.4
The clinical course of noma starts with facial edema, extreme
halitosis and hypersalivation (Figure 1A). Intraoral inspection
may reveal a painful red spot or a necrotizing gingivitis/stomatitis.
Within a few days, a bluish discoloration appears in the edema-
tous region, after which the skin breaks down over the underlying
extensive necrosis. After separation of the gangrenous tissue, a
large hole results often showing devitalized bone that will seques-
ter at a later stage (Figure 1B). If the patient survives, natural
healing frequently leads to amutilated facewith severe functional
impairments like trismus or ankylosis of the mandible, drinking,
eating and speech problems, oral incontinence, and sequelae
often results in social isolation (Figure 1C).
Noma is an old companion of mankind. In previous centuries
the disease has been described commonly in European countries
and the USA.5 It disappeared from these countries due to
increased welfare, enabling even the poorest to adequately feed
their children. The disease has been forgotten and disappeared
almost completely from modern medical textbooks. However,
noma is still present in countries where extreme poverty and mal-
nutrition are prevalent. Global incidence is not well known
because health statistics in less privileged countries do not
include noma as a cause of death. Incidence estimates vary
between 40 000 and 140 000 annually.6 It is assumed that
noma is mainly found in what is called the world’s noma belt:
the part of Africa that lies directly sub-Saharan from Senegal in
the west to Ethiopia in the east. In Central and more Southern
African countries noma is not uncommon, while more incidental
cases have been described in Southeast Asia and in South
America.7 It is enigmatic that on the Indian subcontinent,
where child mortality in absolute numbers is very high, noma is
more or less absent in medical literature.
The mortality rate is not well known. Historical data indicate
that 80–90% of noma patients die due to sepsis. Mortality
decreases signiﬁcantly to around 10–20%when the child receives
medical attention at an early stage of the disease and is treated
with oral antibiotics. Moreover, nutritional support is essential,
treatment of vitamin deﬁciencies, concomitant diseases, and
sometimes parenteral ﬂuids, IV antibiotics and blood transfusion
are needed. However, most noma patients do not have access to
healthcare. The percentage of children with noma who receive
medical treatment is estimated to be 10%, which the authors
consider optimistically high.8 A sound approach for reconstructive
surgical rehabilitation of noma survivors has been described by
Tempest half a century ago and further developed by many
others.1 The authors estimate that only 2–5% of noma survivors
receive any treatment, mainly provided by small NGOs.
The most prominent feature of this brief picture of noma is
omnipresent neglect. This facet of the disease was recognized
long ago by Arnoldus Bootius who included noma in his book
(the ﬁrst one about neglected diseases) ‘Observationes Medicae
de Affectibus Omissis’, published in London in 1649. The present
neglect encompasses not only the social isolation that takes
place due to the often mutilated face and its cultural implications
(bad omens related to bad spirits etc.), but also the lack of access
to both acute medical and later surgical rehabilitation.
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Medical science including microbiology, public health and epi-
demiology, have shown a lack of interest. In the last half century
few microbiological studies have been done on noma. Countries
where noma is prevalent do not include the disease in their
health statistics, nor is it included inWestern-basedmedical teach-
ing programs. With few exceptions, their governments have shown
little interest in the disease and its victims. Health policy makers
prefer to introduce advanced and expensive facilities, such as
dialysis centers or open heart surgery in the capital city, for which
self-interest is a plausible explanation. WHO has not developed
any effective programs aiming at collecting epidemiologic data,
early detection or treatment. None of the editions of the Global
Burden of Disease have paid attention to this affection and noma
does not appear on any list of neglected tropical diseases (NTDs).
A recent estimate of the global burden of disease from noma
resulted in 1.1 million daily-adjusted life years, even if a best case
scenario was assumed, which is high as compared with many
NTDs.9,10 The conclusion that we can draw is that noma belongs
to the special category of ‘neglected-neglected diseases’.
Noma, an indicator of extreme poverty and insufﬁcient food, is
evidence of human rights violations, as advocated by Jean Ziegler,
a Swiss sociologist and member of the Advisory Committee of the
UN Human Rights Council (2008 to 2012). His efforts led to the
adoption of resolution 19/7, ‘The right to food’, by the Human
Rights Council in 2012, with children affected by noma the
prime example of a violation of this right. Noma is evidence of
multiple human rights violations, including the right to clean
water and sanitation, healthcare and adequate housing. Noma
survivors are often excluded from school and jobs and without
access to surgical rehabilitation, often are unable to marry, or to
simply ‘have a life’.
We appeal that noma be added to the list of NTDs, for more
research on its epidemiology and pathogenesis, in particular the
microbiological aspects, for inclusion of the disease in medical
teaching programs in countries where the disease is prevalent
and for surveillance programs in areas where noma is a more
or less a common killer. Humanitarian programs for surgical
rehabilitation of noma survivors need further support. It is high
time that we face ‘the face of poverty’.
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Figure 1. The different stages of noma. A. The ﬁrst stage of noma: facial edema, often accompanied by extreme halitosis and hypersalivation. Gangrene
or its extension can be prevented by administration of antibiotics at this stage. B. The second stage of noma: within a few days gangrene has developed
with the hole in the skin as ‘the tip of the iceberg’ of the necrotic tissue. Administration of antibiotics and other treatment increase survival chance
signiﬁcantly. C. The third stage of noma: often a mutilated face due to tissue loss and wound contracture with impairments such as trismus or
ankylosis of the mandible, eating, drinking and speech problems and social isolation. Surgical rehabilitation may relieve these impairments.
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